Contravisory Investment Management Inc. Sells 328 Shares of Agilent Technologies, Inc. (NYSE:A)
Contravisory Investment Management Inc. cut its position in shares of Agilent Technologies, Inc. (NYSE:A) by 10.8% in the fourth quarter, Holdings Channel reports. The institutional investor owned 2,721 shares of the medical research company’s stock after selling 328 shares during the period. Contravisory Investment Management Inc.’s holdings in Agilent Technologies were worth $322,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Stifel Financial Corp increased its holdings in Agilent Technologies by 102.4% during the 2nd quarter. Stifel Financial Corp now owns 15,748 shares of the medical research company’s stock valued at $1,391,000 after acquiring an additional 7,968 shares in the last quarter. Man Group plc grew its holdings in Agilent Technologies by 209.9% in the second quarter. Man Group plc now owns 50,218 shares of the medical research company’s stock valued at $4,438,000 after purchasing an additional 34,015 shares during the period. Private Advisor Group LLC grew its holdings in Agilent Technologies by 51.6% in the second quarter. Private Advisor Group LLC now owns 6,823 shares of the medical research company’s stock valued at $603,000 after purchasing an additional 2,323 shares during the period. Engineers Gate Manager LP purchased a new stake in Agilent Technologies in the second quarter valued at approximately $1,506,000. Finally, Orion Portfolio Solutions LLC grew its holdings in Agilent Technologies by 17.3% in the second quarter. Orion Portfolio Solutions LLC now owns 1,780 shares of the medical research company’s stock valued at $157,000 after purchasing an additional 263 shares during the period.
In related news, Director Boon Hwee Koh sold 20,000 shares of the company’s stock in a transaction dated Monday, November 30th. The shares were sold at an average price of $114.51, for a total value of $2,290,200.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Michael R. Mcmullen sold 85,842 shares of the company’s stock in a transaction dated Tuesday, December 1st. The shares were sold at an average price of $115.63, for a total transaction of $9,925,910.46. Following the completion of the sale, the chief executive officer now directly owns 415,347 shares of the company’s stock, valued at $48,026,573.61. The disclosure for this sale can be found here. In the last quarter, insiders have sold 112,508 shares of company stock valued at $12,928,428.
Agilent Technologies (NYSE:A) last released its earnings results on Sunday, November 22nd. The medical research company reported $0.98 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.05. Agilent Technologies had a net margin of 13.47% and a return on equity of 21.02%. The firm had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.40 billion. During the same quarter in the previous year, the firm earned $0.89 earnings per share. As a group, analysts expect that Agilent Technologies, Inc. will post 3.67 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 27th. Shareholders of record on Tuesday, January 5th will be paid a dividend of $0.194 per share. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.18. The ex-dividend date of this dividend is Monday, January 4th. This represents a $0.78 annualized dividend and a yield of 0.61%. Agilent Technologies’s payout ratio is presently 23.78%.
A has been the subject of a number of recent analyst reports. Wells Fargo & Company upgraded shares of Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $49.00 target price for the company in a report on Tuesday, December 15th. KeyCorp assumed coverage on shares of Agilent Technologies in a research report on Monday, November 9th. They set an “overweight” rating and a $130.00 price target on the stock. JPMorgan Chase & Co. lifted their price target on shares of Agilent Technologies from $110.00 to $125.00 and gave the company an “overweight” rating in a research report on Tuesday, November 24th. SVB Leerink lifted their price target on shares of Agilent Technologies from $120.00 to $130.00 and gave the company an “outperform” rating in a research report on Thursday, December 10th. Finally, Zacks Investment Research raised shares of Agilent Technologies from a “sell” rating to a “hold” rating and set a $120.00 target price on the stock in a research report on Wednesday, November 25th. Twelve investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. Agilent Technologies presently has a consensus rating of “Buy” and an average price target of $89.74.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass and optical emission spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software, information management, and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Recommended Story: Which market index is the best?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.